Intrinsiqs

Is Boston Scientific Corporation overvalued?

Boston Scientific Corporation (BSX) looks undervalued — trading about 47% below its fair value.

Undervalued
Current price $51.42 Fair value $75.51
Price
$51.42
Fair value
$75.51
Current P/E
26.5
Normal P/E
38.9
Market cap
$76.43B
Dividend yield
0.0%
Return on equity
14.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BSX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.